Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Zeng Y, Hu C, Shu L, Pan Y, Zhao L, Pu X, Wu F (2021) Clinical treatment options for early-stage and advanced conjunctival melanoma. Surv Ophthalmol 66:461–470. https://doi.org/10.1016/j.survophthal.2020.09.004
2. Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S (2009) Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 93:1524–1528. https://doi.org/10.1136/bjo.2009.157933
3. Yu GP, Hu DN, McCormick S, Finger PT (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 135:800–806. https://doi.org/10.1016/s0002-9394(02)02288-2
4. Jia S, Zhu T, Shi H, Zong C, Bao Y, Wen X, Ge S, Ruan J, Xu S, Jia R, Fan X (2022) American Joint Committee on Cancer Tumor Staging System predicts the outcome and metastasis pattern in conjunctival melanoma. Ophthalmology 129:771–780. https://doi.org/10.1016/j.ophtha.2022.02.029
5. Coupland SBR, Conway M, Damato BE, Esmaeli B, Albert DM (2017) The AJCC TNM cancer staging manual, 8th edn. Conjunctival melanoma. Springer Publishing Company, New York